FDA clears blood test to aid evaluation for Alzheimer’s disease
medicine.washu.eduVisit the News Hub Biomarker test is based on technology developed at WashU Medicine Matt Miller/WashU Medicine WashU Medicine’s Randall Bateman, MD, (right) is a co-founder of C2N Diagnostics, a WashU startup that received FDA clearance for its PrecivityAD2 test … Read more